October 21-22, 2014 | Alexandria, VA
Brought to you by NORD; Powered by CBI
NORD’s Rare Diseases and Orphan Products Breakthrough Summit is the largest and most meaningful multistakeholder event of its kind – Featuring over 20 speakers from the FDA, over 80 patient organizations and the Pharma/Biotech industry’s foremost experts in orphan product innovation, investment and commercialization. The 2014 Breakthrough Summit is concentrated with innovative content and convenes the top leaders from the FDA, NIH, Industry, Patient Groups, Payers and Research Institutions to address the progress of rare disease diagnosis, genomics, drug development, patient engagement, product approvals, FDA oversight and market accessibility to orphan products.
Tracking for an unprecedented turnout, with hundreds of executives already registered to attend, the NORD 2014 Breakthrough Summit is crafted with multiple workshops and focused tracks of content to ensure high quality learning, networking and accessibility to thought leaders in the rare disease community.
- Network, learn and benchmark from hundreds of industry counterparts, patient advocacy stakeholders, investors and FDA leadership to better align their thinking on complex issues
- Gain insight into the strategic models for commercializing an orphan product
- Learn strategies to stay ahead of the curve on the newest R&D advancements in rare diagnostics and treatment regimens
*Cannot be combined with other offers or used towards a current registration. Discount valid towards final, standard rate. Other restrictions may apply.